var singsData = [{"date":new Date(2012,1,17),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup downgrades HSP to Sell from Neutral. Target Price is $33; previously $30.","showOnAxis":true},{"date":new Date(2012,1,17),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup downgrades HSP to Sell from Neutral. Target Price is $33; previously $30.","showOnAxis":false},{"date":new Date(2012,10,7),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, HSP reports 2012 Q3's earning $0.47 per share and revenue $994MM. This beats analyst's estimated EPS $0.45, beats estimated revenue $985.64MM.","showOnAxis":false},{"date":new Date(2012,10,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains HSP to Underweight. Target Price is $34; previously $36.","showOnAxis":true},{"date":new Date(2012,10,8),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains HSP to Underweight. Target Price is $34; previously $36.","showOnAxis":false},{"date":new Date(2012,11,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs downgrades HSP to Sell from Neutral.","showOnAxis":true},{"date":new Date(2012,11,11),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs downgrades HSP to Sell from Neutral.","showOnAxis":false},{"date":new Date(2012,4,1),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, HSP reports 2012 Q1's earning $0.24 per share and revenue $965.9MM..","showOnAxis":false},{"date":new Date(2012,7,1),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, HSP reports 2012 Q2's earning $-0.01 per share and revenue $1033MM..","showOnAxis":false},{"date":new Date(2012,7,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan downgrades HSP to Neutral from Overweight. Target Price is $38; previously $40.","showOnAxis":true},{"date":new Date(2012,7,9),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan downgrades HSP to Neutral from Overweight. Target Price is $38; previously $40.","showOnAxis":false},{"date":new Date(2012,8,17),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains HSP to Sell. Target Price is $28; previously $25.","showOnAxis":true},{"date":new Date(2012,8,17),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains HSP to Sell. Target Price is $28; previously $25.","showOnAxis":false},{"date":new Date(2013,1,13),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, HSP reports 2012 Q4's earning $0.55 per share and revenue $1100MM. This beats analyst's estimated EPS $0.54, beats estimated revenue $1040MM.","showOnAxis":false},{"date":new Date(2013,1,13),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bank of America downgrades HSP to Neutral from Buy.","showOnAxis":true},{"date":new Date(2013,1,13),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Bank of America downgrades HSP to Neutral from Buy.","showOnAxis":false},{"date":new Date(2013,1,26),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Gabelli & Co. downgrades HSP to Hold from Buy.","showOnAxis":true},{"date":new Date(2013,1,26),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Gabelli & Co. downgrades HSP to Hold from Buy.","showOnAxis":false},{"date":new Date(2013,10,6),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, HSP reports 2013 Q3's earning $0.51 per share and revenue $1000MM. This beats analyst's estimated EPS $0.45, beats estimated revenue $992.15MM.","showOnAxis":false},{"date":new Date(2013,2,8),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"UBS upgrades HSP to Neutral from Sell.","showOnAxis":false},{"date":new Date(2013,2,8),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"UBS upgrades HSP to Neutral from Sell. Target Price is $30; previously $28.","showOnAxis":false},{"date":new Date(2013,4,1),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, HSP reports 2013 Q1's earning $0.52 per share and revenue $988MM. This beats analyst's estimated EPS $0.44, beats estimated revenue $979.33MM.","showOnAxis":false},{"date":new Date(2013,4,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Raymond James downgrades HSP to Underperform from Market Perform.","showOnAxis":true},{"date":new Date(2013,4,2),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Raymond James downgrades HSP to Underperform from Market Perform.","showOnAxis":false},{"date":new Date(2013,5,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains HSP to Neutral. Target Price is $37; previously $30.","showOnAxis":true},{"date":new Date(2013,5,5),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains HSP to Neutral. Target Price is $37; previously $30.","showOnAxis":false},{"date":new Date(2013,8,26),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Guggenheim initiates coverage on HSP to Buy. Target Price is $49.","showOnAxis":true},{"date":new Date(2013,8,26),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Guggenheim initiates coverage on HSP to Buy. Target Price is $49.","showOnAxis":false},{"date":new Date(2014,1,12),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, HSP reports 2013 Q4's earning $0.51 per share and revenue $1100MM. This beats analyst's estimated EPS $0.5, beats estimated revenue $1060MM.","showOnAxis":false},{"date":new Date(2014,10,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bank of America maintains HSP to Neutral. Target Price is $62; previously $61.","showOnAxis":true},{"date":new Date(2014,10,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains HSP to Equal-Weight. Target Price is $53; previously $47.","showOnAxis":true},{"date":new Date(2014,10,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains HSP to Neutral. Target Price is $56; previously $55.","showOnAxis":true},{"date":new Date(2014,10,7),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Bank of America maintains HSP to Neutral. Target Price is $62; previously $61.","showOnAxis":false},{"date":new Date(2014,10,7),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains HSP to Equal-Weight. Target Price is $53; previously $47.","showOnAxis":false},{"date":new Date(2014,10,7),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains HSP to Neutral. Target Price is $56; previously $55.","showOnAxis":false},{"date":new Date(2014,11,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains HSP to Equal-Weight. Target Price is $56; previously $53.","showOnAxis":true},{"date":new Date(2014,11,11),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains HSP to Equal-Weight. Target Price is $56; previously $53.","showOnAxis":false},{"date":new Date(2014,3,16),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Sterne Agee initiates coverage on HSP to Neutral. Target Price is $39.","showOnAxis":true},{"date":new Date(2014,3,16),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Sterne Agee initiates coverage on HSP to Neutral. Target Price is $39.","showOnAxis":false},{"date":new Date(2014,4,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains HSP to Sell. Target Price is $35; previously $33.","showOnAxis":true},{"date":new Date(2014,4,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Leerink Swann maintains HSP to Market Perform. Target Price is $48; previously $46.","showOnAxis":true},{"date":new Date(2014,4,1),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains HSP to Sell. Target Price is $35; previously $33.","showOnAxis":false},{"date":new Date(2014,4,1),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Leerink Swann maintains HSP to Market Perform. Target Price is $48; previously $46.","showOnAxis":false},{"date":new Date(2014,5,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Wells Fargo initiates coverage on HSP to Market Perform.","showOnAxis":true},{"date":new Date(2014,5,11),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Wells Fargo initiates coverage on HSP to Market Perform.","showOnAxis":false},{"date":new Date(2014,6,30),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Deutsche Bank upgrades HSP to Buy from Hold. Target Price is $61; previously $53.","showOnAxis":false},{"date":new Date(2014,6,31),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains HSP to Equal-Weight. Target Price is $47; previously $43.","showOnAxis":true},{"date":new Date(2014,6,31),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains HSP to Sell. Target Price is $41; previously $35.","showOnAxis":true},{"date":new Date(2014,6,31),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains HSP to Neutral. Target Price is $55; previously $42.","showOnAxis":true},{"date":new Date(2014,6,31),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains HSP to Neutral. Target Price is $57; previously $52.","showOnAxis":true},{"date":new Date(2014,6,31),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains HSP to Equal-Weight. Target Price is $47; previously $43.","showOnAxis":false},{"date":new Date(2014,6,31),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains HSP to Sell. Target Price is $41; previously $35.","showOnAxis":false},{"date":new Date(2014,6,31),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains HSP to Neutral. Target Price is $55; previously $42.","showOnAxis":false},{"date":new Date(2014,6,31),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains HSP to Neutral. Target Price is $57; previously $52.","showOnAxis":false},{"date":new Date(2015,0,15),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains HSP to Buy. Target Price is $67; previously $63.","showOnAxis":true},{"date":new Date(2015,0,15),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains HSP to Buy. Target Price is $67; previously $63.","showOnAxis":false},{"date":new Date(2015,1,6),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Goldman Sachs upgrades HSP to Neutral from Sell. Target Price is $68; previously $51.","showOnAxis":false}];